Latest News

Ring in the New Year with "Utano Princesama Shining Live" Campaigns

TOKYO, Jan. 4, 2022 /PRNewswire/ -- KLab Inc., a leader in online mobile games, together with BROCCOLI Co., Ltd., announced that its smartphone rhythm game Utano Princesama Shining Livecelebrated the new year with the start of the New Year's 2022 Campaign. Players can enjoy the New Year's campaign...

2022-01-04 17:50 2660

Harbour BioMed Announces Dosing of First Patient of Two Phase I Trials for Next-Generation Anti-CTLA-4 Antibody HBM4003

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Jan. 4, 2022 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, its next generation anti-CTLA-4 fully human heavy-chain only antibody (HCAb), HBM4003, has completed the first dosing of first patient in two phase I tri...

2022-01-04 17:28 2737

Perfect combination of low power and high performance: Infineon introduces the new AIROC(TM) CYW20829 Bluetooth(R) LE system on chip

MUNICH, Jan. 4, 2022 /PRNewswire/ -- Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) is launching the AIROC™ CYW20829 Bluetooth® LE system on chip (SoC). The AIROC CYW20829 Bluetooth LE SoC is a Bluetooth 5.3 core spec-compliant device for IoT, smart home and industrial applications. With the ...

2022-01-04 17:05 3544

Alamar Biosciences partners with Abcam to drive understanding of the human proteome

FREMONT, Calif. and CAMBRIDGE, England, Jan. 4, 2022 /PRNewswire/ -- Alamar Biosciences  (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM: ABC...

2022-01-04 17:00 3110

China's Shihezi city delights Times Square with fruits of green development

SHIHEZI, China, Jan. 4, 2022 /PRNewswire/ -- According to Xinhua Screen Media Co., Ltd., its big screen measuring 19.5 meters high and 12.2 meters wide inNew York's Times Square, dubbed "crossroads of the World", repeatedly played a promotional video from the Chinese city of Shihezi before Christ...

2022-01-04 16:53 3715

Xinhua Silk Road: Yubei District of SW. China's Chongqing to build high-quality economic zone in 5 years

BEIJING, Jan. 4, 2022 /PRNewswire/ -- Yubei District of southwest China's Chongqing Municipality will accelerate the construction of a high-quality economic zone, an airport economic zone with high-level opening-up, a sci-tech innovation area with high energy capacity and an urban-rural area with...

2022-01-04 16:48 3824

Livegenic and Service Certainty Partner to Provide Leading-edge Video Collaboration Solutions

SYDNEY, Jan. 4, 2022 /PRNewswire/ -- Global insurance technology solutions provider Wilbur (https://www.wilbur.io/ ) (parent of Livegenic) has announced a partnership with theUnited Kingdom's largest network of professional photographers, Service Certainty ( https://www.se...

2022-01-04 16:00 2513

Affiliates Flock to Seal Partnerships with Malaysia Healthcare at Expo 2020 Dubai

DUBAI, UAE, Jan. 4, 2022 /PRNewswire/ -- Malaysia's healthcare travel industry led by the Malaysia Healthcare Travel Council (MHTC), welcomed more new partnerships at the Malaysia Pavilion in Expo 2020 Dubai. Memorandums of Understanding (MoUs) were exchanged with renowned players such as Interna...

2022-01-04 15:32 2466

ASEAN Leaders Must See Funding For Sustainability As An Investment Not A Cost, To Achieve Better Trading Opportunities

PETALING JAYA, Malaysia, Jan. 4, 2022 /PRNewswire/ -- For ASEAN to accelerate and meet the requirements by its global partners for greater sustainable trade and commerce, leaders must adopt a mega shift in behaviour and mindset. They must recognise that sustainability will require fundings and it...

2022-01-04 12:54 2690

Xinhua Silk Road: Chery's NEV QQ Ice Cream unveiled at a cultural festival in Wuhu, Anhui

BEIJING, Jan. 4, 2022 /PRNewswire/ -- Chery Automobile has launched its first new energy vehicle (NEV) QQ Ice Cream recently, in light of which Wuhu City of eastChina's Anhui Province held a cultural festival on December 28 to not only introduce the new auto product, but also promote Wuhu's tradi...

2022-01-04 12:39 6781

Shiyu Wang Rejoins Qiming Venture Partners as Partner, Co-Leads TMT Team

SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm inChina, is pleased to announce that Shiyu Wang has rejoined the firm as a Partner.Shiyu Wang will co-lead the TMT team, managing and investing in the internet and consumer sectors. Shiyu Wang has many...

2022-01-04 12:11 3733

CGTN: CMG president delivers New Year message to overseas audience

BEIJING, Jan. 4, 2022 /PRNewswire/ -- Shen Haixiong, president of China Media Group (CMG), extended New Year greetings in an address to overseas audiences via CGTN, China Radio International, and through the internet onJanuary 1, 2022.   CMG President Shen Haixiong said 2021 was...

2022-01-04 11:10 3673

Spreading the wing to enter Taiwan's robotics market to catch up with AMR trend

TAIPEI, Jan. 4, 2022 /PRNewswire/ -- All major robotic manufacturers invested a lot to keep up with the trend of AMR. In the Automation Taipei exhibition, many players have launched their flagship AMR products that drew people's attention.

2022-01-04 10:05 3072

Prudential Singapore boosts support for SMEs in their digitalisation efforts and business growth

SINGAPORE, Jan. 4, 2022  /PRNewswire/ -- Prudential Singapore ("Prudential") has partnered Ngee Ann Polytechnic ("Ngee Ann Poly") and ST Engineering to equip small and medium-sized enterprises (SMEs) with the knowledge and resources on how to go digital in a safe and secure manner.

2022-01-04 10:05 4217

Gaw NP Industrial opens second ready-built-factory as demand soars in Vietnam

THAI NGUYEN, Vietnam, Jan. 4, 2022 /PRNewswire/ -- Gaw NP Industrial (GNP) broke ground onDecember 28, 2021 for its second premium ready-built-factory (RBF) project, the GNP Yen Binh 2 - Industrial Center. GNP Yen Binh 2 is designed to cater to ...

2022-01-04 10:00 8199

Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002

SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Joint research results from Biologics of Jemincare and Shanghai Institute ofMateria Medica (SIMM) of Chinese Academy of Sciences (CAS) confirmed that JMB2002, an anti-SARS-CoV-2 neutralizing antibody (NAb) discovered by Biologics of Jemincare is still effect...

2022-01-04 10:00 5572

AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH CONCURRENT CHEMORADIOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE III CLINICAL TRIAL FOR THE TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER

HONG KONG, Jan. 3, 2022 /PRNewswire/ -- Today, Akeso (09926.HK) announces that Cadonilimab (PD-1/ CTLA-4 bi-specific antibody), the first-inclass novel immuno-oncology drug independently developed by the Company, combined with concurrent chemoradiotherapy obtained approval from the Center for Dru...

2022-01-04 10:00 3183

TCI's Golden Formula Has Won the Best Plant-Based Functional Product in the World Plant-Based Awards 2021

TAIPEI, Jan. 3, 2022 /PRNewswire/ -- In recent years, there has been a global trend of plant-based health care, which is known as vegetarian food in Taiwan. In the World Plant-Based Awards, jointly organized by FoodBev Media and Plant Based World Expo & Conference, TCI's Golden Formula won the be...

2022-01-04 09:00 2917

SK Group strengthens its commitment to Malaysia with over $700m investments including Digital Bank and EV

KUALA LUMPUR, Malaysia, Jan. 4, 2022 /PRNewswire/ -- SK Group, the second largest conglomerate in Korea with a market capitalization of$177bn, has committed over$700m investments in Malaysia in 2021, and intends to invest further into the country moving forward. In January 2021, SK Nexilis annou...

2022-01-04 09:00 3687

Gannex Announces Completion of the U.S. Phase I Trial of ASC43F, an In-House Developed First-in-Class Dual Targeting Fixed-dose Combination Tablet for NASH

* ASC43F was safe and well tolerated in healthy subjects with no clinically significant study drug related adverse events * Pharmacokinetic parameters of ASC41 and ASC42 from ASC43F are similar to those of ASC41 and ASC42 monotherapy * Phase I trial completed two months after the U.S. IND ap...

2022-01-04 08:30 4628